# Phase I/II Hypofractionated Radiotherapy for Prostate Cancer

> **NCT00214097** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 347 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT00214097
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10-14
- **Primary completion:** 2017-08-21
- **Final completion:** 2017-08-21
- **Target enrollment:** 347 (ACTUAL)
- **Last updated:** 2019-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00214097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00214097, "Phase I/II Hypofractionated Radiotherapy for Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00214097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*